China Life Insurance plans to invest 2.8 billion yuan to participate in the establishment of Fujian Province Xinrui Science and Technology Innovation Relay Equity Investment Fund.
China Life Insurance (601628.SH) announced that the company, Fujian Provincial Government Investment Fund Co., Ltd. ("Fujian Government Investment"), and Fuzhou City Jintou Industrial Investment Co., Ltd. ("Fuzhou Jintou") (all parties as limited partners) plan to enter into a partnership agreement with Guangzhou Jinhong Zhiyuan Industrial Investment Co., Ltd. ("Jinhong Zhiyuan") (as a general partner) and Fuzhou Herui Industrial Investment Partnership Enterprise (limited partnership) (the final name subject to business registration information) ("Fuzhou Herui") (as a special limited partner) to establish Fujian Province Xinrui Technology Innovation Relay Equity Investment Fund Partnership Enterprise (limited partnership) (the final name subject to business registration information).
China Life Insurance (601628.SH) announced that the company, Fujian Provincial Government Investment Fund Co., Ltd. ("Fujian Government Investment"), and Fuzhou Jintou Industrial Investment Co., Ltd. ("Fuzhou Jintou") (each as a limited partner) intend to enter into a partnership agreement with Guangzhou Jinhong Zhiyuan Industrial Investment Co., Ltd. ("Jinhong Zhiyuan") (as a general partner) and Fuzhou He Rui Industrial Investment Partnership Enterprise (limited partnership) (the final name subject to business registration information) ("Fuzhou He Rui") (as a special limited partner) to establish the Fujian Province Xin Rui Innovation Relay Equity Investment Fund Partnership Enterprise (limited partnership) (the final name subject to business registration information). The total amount of capital contributions proposed by all partners of the partnership enterprise is RMB 4.0154 billion, of which the company's proposed contribution is RMB 2.8 billion. China Life Insurance Goldstone Asset Management Co., Ltd. ("China Life Goldstone") will act as the manager of the partnership enterprise.
The investment of the partnership enterprise will focus on the field of technological innovation, seize the development dividends of science and technology innovation, and indirectly invest in equity assets in the growth stage and mature stage through the investment fund secondary shares and follow-up reorganization fund.
Related Articles

From turning point of profit to platform going overseas, the 2025 report reveals the advanced path of Lepubio Biopharma (02157).

WUXI BIO (02269) issues a total of 25,575,000 restricted shares.

KINGSOFT CLOUD (KC.US) continues to expand the boundaries of AI capabilities, and Smart Cloud activates new growth momentum.
From turning point of profit to platform going overseas, the 2025 report reveals the advanced path of Lepubio Biopharma (02157).

WUXI BIO (02269) issues a total of 25,575,000 restricted shares.

KINGSOFT CLOUD (KC.US) continues to expand the boundaries of AI capabilities, and Smart Cloud activates new growth momentum.






